199 related articles for article (PubMed ID: 12431311)
1. Effects of sympathetic stimulation on various repolarization indices in the congenital long QT syndrome.
Shimizu W
Ann Noninvasive Electrocardiol; 2002 Oct; 7(4):332-42. PubMed ID: 12431311
[TBL] [Abstract][Full Text] [Related]
2. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome.
Tanabe Y; Inagaki M; Kurita T; Nagaya N; Taguchi A; Suyama K; Aihara N; Kamakura S; Sunagawa K; Nakamura K; Ohe T; Towbin JA; Priori SG; Shimizu W
J Am Coll Cardiol; 2001 Mar; 37(3):911-9. PubMed ID: 11693770
[TBL] [Abstract][Full Text] [Related]
3. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
Antzelevitch C; Yan GX; Shimizu W
J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
Shimizu W; Antzelevitch C
J Am Coll Cardiol; 2000 Mar; 35(3):778-86. PubMed ID: 10716483
[TBL] [Abstract][Full Text] [Related]
5. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
Shimizu W; McMahon B; Antzelevitch C
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
[TBL] [Abstract][Full Text] [Related]
6. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
7. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Shimizu W; Antzelevitch C
Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
[TBL] [Abstract][Full Text] [Related]
8. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome.
Yan GX; Antzelevitch C
Circulation; 1998 Nov; 98(18):1928-36. PubMed ID: 9799215
[TBL] [Abstract][Full Text] [Related]
9. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
Shimizu W; Antzelevitch C
J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
[TBL] [Abstract][Full Text] [Related]
10. Response of beat-by-beat QT variability to sympathetic stimulation in the LQT1 form of congenital long QT syndrome.
Satomi K; Shimizu W; Takaki H; Suyama K; Kurita T; Aihara N; Kamakura S
Heart Rhythm; 2005 Feb; 2(2):149-54. PubMed ID: 15851288
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome.
Shimizu W; Tanabe Y; Aiba T; Inagaki M; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Sunagawa K; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
J Am Coll Cardiol; 2002 Jun; 39(12):1984-91. PubMed ID: 12084597
[TBL] [Abstract][Full Text] [Related]
12. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome.
Noda T; Takaki H; Kurita T; Suyama K; Nagaya N; Taguchi A; Aihara N; Kamakura S; Sunagawa K; Nakamura K; Ohe T; Horie M; Napolitano C; Towbin JA; Priori SG; Shimizu W
Eur Heart J; 2002 Jun; 23(12):975-83. PubMed ID: 12069453
[TBL] [Abstract][Full Text] [Related]
13. Cellular basis for QT dispersion.
Antzelevitch C; Shimizu W; Yan GX; Sicouri S
J Electrocardiol; 1998; 30 Suppl():168-75. PubMed ID: 9535495
[TBL] [Abstract][Full Text] [Related]
14. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
Shimizu W; Antzelevitch C
Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
[TBL] [Abstract][Full Text] [Related]
15. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
[TBL] [Abstract][Full Text] [Related]
16. Cellular and ionic basis for T-wave alternans under long-QT conditions.
Shimizu W; Antzelevitch C
Circulation; 1999 Mar; 99(11):1499-507. PubMed ID: 10086976
[TBL] [Abstract][Full Text] [Related]
17. Catecholamines in children with congenital long QT syndrome and Brugada syndrome.
Shimizu W; Kamakura S
J Electrocardiol; 2001; 34 Suppl():173-5. PubMed ID: 11781952
[TBL] [Abstract][Full Text] [Related]
18. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
Shimizu W; Aiba T; Antzelevitch C
Curr Pharm Des; 2005; 11(12):1561-72. PubMed ID: 15892662
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome.
Shimizu W; Noda T; Takaki H; Nagaya N; Satomi K; Kurita T; Suyama K; Aihara N; Sunagawa K; Echigo S; Miyamoto Y; Yoshimasa Y; Nakamura K; Ohe T; Towbin JA; Priori SG; Kamakura S
Heart Rhythm; 2004 Sep; 1(3):276-83. PubMed ID: 15851169
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of the long QT syndrome: impact on management.
Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
